UM171 Cell Therapy

UM171 Cell Therapy is a proprietary advanced clinical stage investigational drug product consisting of UM171-expanded hematopoietic stem cells (HSCs) used to treat blood cancers, including leukemias and myelodysplasias.

Cordex
Biologics

UM171 Cell Therapy is now part of Cordex Biologics Inc., a wholly owned subsidiary of ExCellThera.